{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:46:08Z","timestamp":1790027168328,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jaci.2013.09.019","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T03:48:39Z","timestamp":1383277719000},"page":"1065-1074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions"],"prefix":"10.1016","volume":"133","author":[{"given":"Asako","family":"Ichihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Jinnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Izuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Shimozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Ihn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2013.09.019_bib1","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2013.09.019_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2013.09.019_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jdermsci.2008.10.004","article-title":"MicroRNAs and the skin: tiny players in the body's largest organ","volume":"53","author":"Sand","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2013.09.019_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.sbi.2005.05.006","article-title":"Post-transcriptional gene silencing by siRNAs and miRNAs","volume":"15","author":"Filipowicz","year":"2005","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.jaci.2013.09.019_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2013.09.019_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.jaci.2013.09.019_bib7","first-page":"95","article-title":"Importance of microRNAs in skin morphogenesis and diseases","volume":"17","author":"Bostjancic","year":"2008","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1016\/j.jaci.2013.09.019_bib8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00125-010-1667-2","article-title":"Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes","volume":"53","author":"Herrera","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaci.2013.09.019_bib9","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood-2007-07-104133","article-title":"Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.09.019_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.2009.05121.x","article-title":"MicroRNAs of the immune system: roles in inflammation and cancer","volume":"1183","author":"Davidson-Moncada","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2013.09.019_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tips.2007.10.014","article-title":"Targeting microRNA expression to regulate angiogenesis","volume":"29","author":"Kuehbacher","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jaci.2013.09.019_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2010.02.005","article-title":"The role of microRNA in rheumatoid arthritis and other autoimmune diseases","volume":"136","author":"Furer","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2013.09.019_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12265-010-9169-7","article-title":"MicroRNA-21 in cardiovascular disease","volume":"3","author":"Cheng","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.jaci.2013.09.019_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2010.03.069","article-title":"MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases","volume":"1338","author":"Provost","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.jaci.2013.09.019_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2133\/dmpk.DMPK-11-RV-116","article-title":"A recent update of pharmacogenomics in drug-induced severe skin reactions","volume":"27","author":"Wei","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jaci.2013.09.019_bib16","doi-asserted-by":"crossref","first-page":"e14334","DOI":"10.1371\/journal.pone.0014334","article-title":"Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy","volume":"5","author":"Nakashima","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2013.09.019_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)","volume":"50","author":"Kroh","year":"2010","journal-title":"Methods"},{"key":"10.1016\/j.jaci.2013.09.019_bib18","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.09.019_bib19","doi-asserted-by":"crossref","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","article-title":"Serum microRNAs are promising novel biomarkers","volume":"3","author":"Gilad","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2013.09.019_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1756-0500-2-89","article-title":"Circulating microRNAs in breast cancer and healthy subjects","volume":"2","author":"Zhu","year":"2009","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jaci.2013.09.019_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jdermsci.2010.12.010","article-title":"The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker","volume":"61","author":"Kanemaru","year":"2011","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2013.09.019_bib22","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1158\/0008-5472.CAN-04-3586","article-title":"Epidermal growth factor receptor dynamics influences response to epidermal growth factor receptor targeted agents","volume":"65","author":"Jimeno","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2013.09.019_bib23","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.yexcr.2011.05.019","article-title":"Claudin-7 inhibits human lung cancer cell migration and invasion through ERK\/MAPK signaling pathway","volume":"317","author":"Lu","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jaci.2013.09.019_bib24","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.09.019_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbrc.2010.12.053","article-title":"MicroRNA-101 downregulates Alzheimer's amyloid-\u03b2 precursor protein levels in human cell cultures and is differentially expressed","volume":"404","author":"Long","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2013.09.019_bib26","doi-asserted-by":"crossref","first-page":"40142","DOI":"10.1074\/jbc.M111.251793","article-title":"MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes","volume":"286","author":"Brock","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2013.09.019_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1365-2133.2012.11022.x","article-title":"Expression of microRNAs in basal cell carcinoma","volume":"167","author":"Sand","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.09.019_bib28","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/bjc.2011.453","article-title":"Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer","volume":"105","author":"Morimura","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaci.2013.09.019_bib29","doi-asserted-by":"crossref","first-page":"e25454","DOI":"10.1371\/journal.pone.0025454","article-title":"miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase","volume":"6","author":"Song","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2013.09.019_bib30","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1349-7006.2008.00800.x","article-title":"Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells","volume":"99","author":"Takakura","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jaci.2013.09.019_bib31","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/j.1349-7006.2011.02081.x","article-title":"miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer","volume":"102","author":"Tsuchida","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jaci.2013.09.019_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/path.2811","article-title":"BCL2L10 protein regulates apoptosis\/proliferation through differential pathways in gastric cancer cells","volume":"223","author":"Xu","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.jaci.2013.09.019_bib33","doi-asserted-by":"crossref","first-page":"BR60","DOI":"10.12659\/MSM.882205","article-title":"Apoptosis-associated genes and their role in predicting responses to neoadjuvant breast cancer treatment","volume":"18","author":"Tvrd\u00edk","year":"2012","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jaci.2013.09.019_bib34","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/leu.2011.170","article-title":"Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine","volume":"25","author":"Voso","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2013.09.019_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gene.2004.02.017","article-title":"Comparative genomics: the evolutionary history of the Bcl-2 family","volume":"333","author":"Lanave","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.jaci.2013.09.019_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaci.2013.09.019_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cell.2011.02.034","article-title":"Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol","volume":"145","author":"Edlich","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2013.09.019_bib38","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1133289","article-title":"Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak","volume":"315","author":"Willis","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jaci.2013.09.019_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molcel.2010.01.025","article-title":"The BCL-2 family reunion","volume":"37","author":"Chipuk","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.jaci.2013.09.019_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaad.2010.04.042","article-title":"Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"65","author":"Fujita","year":"2011","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913014632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913014632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:45:08Z","timestamp":1758789908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674913014632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0091674913014632"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2013.09.019","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2013.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}